U.S. to produce cell-based flu vaccine
TMCnet - The World's Largest Communications and Technology Community
TMC Launches New Sites ::  4GWE  |  Satellite  |  IT |  Business Video  |  Healthcare  |  Smart Grid  |  M2M  |  Smart Products  | 
Share
TMCnews
[January 15, 2009]

U.S. to produce cell-based flu vaccine

(UPI Science News Via Acquire Media NewsEdge) The U.S. government said it has awarded a $487 million contract to Novartis Vaccines and Diagnostics for cell-based flu vaccines.

Novartis will be the first U.S. facility to manufacture cell-based vaccines, which can be made faster and in greater quantities than traditional influenza vaccine. The Department of Health and Human Services said the new facility is expected to boost U.S. capacity for pandemic influenza vaccine by at least 25 percent.



Currently, influenza vaccines licensed by the Food and Drug Administration are made in specialized chicken eggs using a process that has changed little over the past five decades.

In place of eggs, cell-based vaccine production uses laboratory-grown cells that are capable of hosting a growing virus. The virus is injected into the cells where it multiplies. The cells' outer walls are then removed, harvested, purified, and inactivated. Cell-based vaccines can be produced in a matter of weeks, much faster than egg-based vaccines, HHS said Thursday.



Novartis and HHS will share the cost of the new cell-based influenza vaccine manufacturing facility in Holly Springs, N.C.,

Copyright ? 2009 United Press International

[ Back To TMCnet.com's Homepage ]


Discussions:
Be the first to post a comment on this page!
 
By  
TMCnet
Featured White Papers
Top Stories
Related VoIP News

Today @ TMC
Upcoming Events
ITEXPO West 2010
October 4-6, 2010
Los Angeles Convention Center
in Los Angeles, CA
4G Wireless Evolution Conference
October 4-6, 2010
Los Angeles Convention Center
in Los Angeles, CA
Subscribe FREE to all of TMC's monthly magazines. Click here now.